BioCentury
ARTICLE | Company News

Isconova, Tripep deal

May 12, 2003 7:00 AM UTC

TPEP plans to acquire vaccine company Isconova, which will become a wholly owned subsidiary of TPEP. Isconova shareholders will receive 2 million TPEP shares plus 75% of Isconova's net profits from it...